Azenta has expanded its GENEWIZ business capabilities through an exclusive licensing deal with Elegen, which offers advanced cell-free DNA synthesis technology, and by acquiring SynPlexity, a synthetic biology firm specializing in high-throughput gene libraries. These moves enhance DNA quality, speed, and scalability, and support large-scale biological design and AI-driven drug discovery. The investments aim to strengthen GENEWIZ's market position and accelerate growth in synthetic biology and biologics development. Further details will be shared in Azenta's Q4 fiscal 2026 earnings call.
Azenta's strategic investments in gene synthesis capabilities provide context for the health sector market snapshot on Pluang as of Oct 30, 2026 18:43 WIB: Among 150 priced health-sector US stocks, 71 rose and 72 fell. Notable movers include Regeneron Pharmaceuticals Inc (REGN) at USD 885.30 with a 1-day change of +8.13% and a typical hold time of 108 days, Twist Bioscience Corp (TWST) at USD 161.99 with a -6.61% change and a 36% sell / 64% buy order activity, and BrightSpring Health Services Inc. (BTSG) at USD 64.06 with a +6.38% change and 90% buy order activity. The most notable figure is REGN's 8.13% gain.
FreightCar America disclosed on October 19, 2026, that it removed 1,285 railcars from its backlog after a customer was unlikely to fulfill contractual obligations, causing its stock to drop 31.4% to $4.02. This sharp decline has led Glancy Prongay Wo...
FirstCash Holdings, Inc. shares fell 14.75% following the October 22, 2026 disclosure of its third quarter financial results, which showed a 28% year-over-year decline in operating income for its American First Finance segment to $33 million. The com...
The global screw compressors market is projected to grow from $13.97 billion in 2026 to $18.38 billion by 2031, at a CAGR of 5.66%. Growth is fueled by rising industrial automation, energy-efficiency regulations, and demand in manufacturing, oil and ...
Enova International's stock fell 23.43% after the company withdrew its application to acquire Grasshopper Bancorp and become a bank holding company. The withdrawal was due to unclear regulatory standards and political pressures cited by Enova. This s...
The global dialysis machines market is forecasted to grow from $17.89 billion in 2026 to $31.54 billion by 2035, at a CAGR of 6.5%. Growth is fueled by rising chronic kidney disease cases, expanding dialysis infrastructure, and innovations like home ...
